6SS-31870-33440
5 vaccinations
7 coded responses
60 check-ins
5 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 51-55
- ZIP prefix
- 303 / GA
- Registered
- 2021-03-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-08
Registered in v-safe
-
2021-03-08
Dose 1 — Pfizer-BioNTech
- 2021-03-08
-
2021-03-09
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, Abdominal painAdult check-in
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-22
-
2021-03-29
Dose 2 — Pfizer-BioNTech
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-12
- 2021-04-19
- 2021-04-26
- 2021-05-03
- 2021-05-10
- 2021-06-29
-
2021-09-27
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2021-09-27
Survey response — 6 months, dose 2MedDRA: SARS-CoV-2 test positive — Feeling: GoodFree text: Tested positive for COVID-19. Negligible symptoms, really only noticeable in hindsight. No-one I can into contact with prior to the positive result tested positive.MedDRA releases: 2024-11 · check-in free text available
- 2021-10-03
- 2021-10-04
- 2021-10-13
- 2021-10-18
- 2021-10-25
- 2021-11-01
- 2021-11-08
- 2021-12-27
-
2022-03-28
Survey response — 6 months, dose 3MedDRA: Influenza, SARS-CoV-2 test positive — Feeling: GoodFree text: Flu symptoms, tested positive for COVID-19MedDRA releases: 2024-11 · check-in free text available
-
2022-05-26
Dose 4 — Pfizer-BioNTech
- 2022-05-26
-
2022-05-27
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-05-28
- 2022-05-29
- 2022-05-30
- 2022-06-01
- 2022-06-02
- 2022-06-09
- 2022-06-16
- 2022-06-23
- 2022-06-30
- 2022-07-07
-
2022-08-25
Survey response — 3 months, dose 4MedDRA: Bronchitis, SARS-CoV-2 test negative — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Bronchitis, possible pneumonia, lingered for 2-3 weeks. Did two at-home COVID tests, both negative, but not convinced it wasn't COVID (a third time). Might be suffering form long COVID.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-25
Report sent to call center — 3 months, dose 4Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-08-26
Call successfulParticipant prefers to complete VAERS report online
-
2022-10-19
Dose 5 — Pfizer-BioNTechCo-administered: Flu
-
2022-10-20
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-10-21
- 2022-10-22
-
2022-10-23
Survey response — days 1–6 daily, dose 5MedDRA: Nasal congestion — Feeling: GoodFree text: nasal congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-10-24
- 2022-10-25
- 2022-10-26
- 2022-11-02
- 2022-11-09
- 2022-11-16
- 2022-11-23
-
2022-11-30
Survey response — day 42, dose 5MedDRA: Asthma, Cough, Influenza, Lung disorder, Nasal congestion, Nasopharyngitis, Sinus headache — Feeling: GoodFree text: Cold or flu, not serious. Nasal congestion, sinus headache, lungs affected (asthma playing up), coughing.MedDRA releases: 2024-11 · check-in free text available
-
2023-01-19
Survey response — 3 months, dose 5MedDRA: Cough, Respiratory tract congestion — Feeling: GoodMedDRA releases: 2024-11
-
2023-04-19
Survey response — 6 months, dose 5MedDRA: Nasal congestion, Sinus headache, Upper-airway cough syndrome — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Pfizer-BioNTech | |
| 2 | 2021-03-29 | Pfizer-BioNTech | |
| 3 | 2021-09-27 | Pfizer-BioNTech | Flu |
| 4 | 2022-05-26 | Pfizer-BioNTech | No |
| 5 | 2022-10-19 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 successful
Free text
Release 9 — 6 months, dose 2
Symptoms: Tested positive for COVID-19. Negligible symptoms, really only noticeable in hindsight. No-one I can into contact with prior to the positive result tested positive.
Release 11 — 6 months, dose 3
Symptoms: Flu symptoms, tested positive for COVID-19
Release 12 — 3 months, dose 4
Symptoms: Bronchitis, possible pneumonia, lingered for 2-3 weeks. Did two at-home COVID tests, both negative, but not convinced it wasn't COVID (a third time). Might be suffering form long COVID.
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): nasal congestion
Release 12 — day 42, dose 5
Symptoms: Cold or flu, not serious. Nasal congestion, sinus headache, lungs affected (asthma playing up), coughing.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | · | · | ✓ |
| SD | Bronchitis | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Lung disorder | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Sinus headache | · | · | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
| SRO | Nasal congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release